November 25, 2022 from MMJDaily
In a significant step for the UK medical cannabis industry, on 16 November 2022, the Medicines and Healthcare products Regulatory Agency of the UK Government (MHRA) made an announcement clarifying the process for a company to be authorized to grow and manufacture medical cannabis commercially.
The MHRA process involves a series of checks, inspections, and validations involving both the UK Home Office and the MHRA.
Previously, there has been no formalized joint approach to medical cannabis cultivation and manufacturing from the Home Office and the MHRA.
